A Novel de novo KIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, and Spastic Paraplegia.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Mar 2020
Historique:
pubmed: 10 12 2019
medline: 24 9 2020
entrez: 10 12 2019
Statut: ppublish

Résumé

Heterozygous mutations in KIF1A have been reported to cause syndromic intellectual disability or pure spastic paraplegia. However, their genotype-phenotype correlations have not been fully elucidated. We herein report a man with autism and hyperactivity along with sensory disturbance and spastic paraplegia, carrying a novel de novo mutation in KIF1A [c.37C>T (p.R13C)]. Autism and hyperactivity have only previously been reported in a patient with c.38 G>A (R13H) mutation. This case suggests that alterations in this arginine at codon 13 might lead to a common clinical spectrum and further expand the genetic and clinical spectra associated with KIF1A mutations.

Identifiants

pubmed: 31813911
doi: 10.2169/internalmedicine.3661-19
pmc: PMC7118386
doi:

Substances chimiques

KIF1A protein, human 0
Kinesins EC 3.6.4.4

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

839-842

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
PLoS One. 2017 Mar 31;12(3):e0174667
pubmed: 28362824
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt B):328-342
pubmed: 28935587
EMBO J. 2016 Feb 1;35(3):302-18
pubmed: 26758546
Hum Mutat. 2015 Jan;36(1):69-78
pubmed: 25265257
Nat Commun. 2016 Sep 23;7:12741
pubmed: 27658622
Eur J Hum Genet. 2015 Oct;23(10):1427-30
pubmed: 25585697
Am J Hum Genet. 2011 Mar 11;88(3):306-16
pubmed: 21376300
Ann Clin Transl Neurol. 2015 Jun;2(6):623-35
pubmed: 26125038
J Hum Genet. 2015 Dec;60(12):739-42
pubmed: 26354034
Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):951-7
pubmed: 23038421
J Child Neurol. 2016 Aug;31(9):1114-9
pubmed: 27034427
Clin Genet. 2018 Feb;93(2):301-309
pubmed: 28708278
Neuron. 2012 Feb 23;73(4):743-57
pubmed: 22365548
Neuron. 2016 Jun 15;90(6):1215-1229
pubmed: 27263974
Cell. 1995 Jun 2;81(5):769-80
pubmed: 7539720
Genome Res. 2011 May;21(5):658-64
pubmed: 21487076
Am J Hum Genet. 2011 Aug 12;89(2):219-30
pubmed: 21820098
J Biol Chem. 2003 Mar 28;278(13):11393-401
pubmed: 12522103
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Peripher Nerv Syst. 2017 Dec;22(4):460-463
pubmed: 28834584
J Neurol. 2015 Dec;262(12):2684-90
pubmed: 26410750

Auteurs

Masanori Kurihara (M)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Hiroyuki Ishiura (H)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Taro Bannai (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Jun Mitsui (J)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Jun Yoshimura (J)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Japan.

Shinichi Morishita (S)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Japan.

Toshihiro Hayashi (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Department of Physiology, Teikyo University School of Medicine, Japan.

Jun Shimizu (J)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Tatsushi Toda (T)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Shoji Tsuji (S)

Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan.
Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH